The Journal of Organic Chemistry
Article
Hydrolysis of Oxidized Oligodeoxynucleotides and λ-DNA.
The oxidized ODN or λ-DNA samples were hydrolyzed to the free
bases for HPLC analysis. The hydrolysis was performed on the
oxidized and lyophilized DNA by adding 50 μL of 70% HF in pyridine
for 30 min at 37 °C. After the reaction, the excess HF was neutralized
by adding 1 mL of ddH2O and 80 mg of CaCO3 to the sample. The
insoluble salts were removed by centrifugation, and the supernatant
was then lyophilized to dryness. Next, the lyophilized samples were
dissolved in ddH2O and submitted to LC-MS and HPLC analysis as
described for the nucleoside studies below.
ACKNOWLEDGMENTS
■
The authors are grateful to Dr. James Muller (University of
Utah) for his assistance with mass spectrometry and to the
National Institutes of Health for financial support (R01
CA090689).
REFERENCES
■
(1) Sies, H. Klin. Wochenschr. 1991, 69, 965−968.
(2) Breen, A. P.; Murphy, J. A. Free Radic. Biol. Med. 1995, 18, 1033−
1077.
Product Identification. Product identification was initially
achieved by UPLC-ESI+-MS (100 mm × 2.1 mm, 1.7 μm) and
UPLC-ESI+-MS with a Hypercarb column (100 mm × 2.1 mm, 5
μm). Then, each compound was HPLC purified for further structural
analysis. The following masses were observed: Gua m/z [M + H]+
calcd 152.1, found 152.1. OG m/z [M + H]+ calcd 168.1, found 168.1.
dOG m/z [M + H]+ calcd 284.2, found 284.1. R and S diastereomers
of cyclo-dG m/z [M + H]+ calcd 266.2, found 266.1. Gh m/z [M +
H]+ calcd 158.1, found 158.1. (S)-d2Ih and (R)-d2Ih42 m/z [M + H]+
calcd 302.3, found 302.1; ESI+-MS/MS m/z [M + H]+ lit.37 186, 158,
and 141; found 186, 158, and 141. HRMS (ESI-TOF) m/z [M + Na]+
calcd for C5H7N5O3Na 208.0447, found 208.0449. The HRMS value
was obtained on the free base 2Ih, due to the nucleoside’s instability
toward acid. dGh m/z [M + H]+ calcd 274.3, found 274.1; HRMS
(ESI-TOF) m/z [M + Na]+ calcd for C9H15N5O5Na 296.0971, found
296.0980. (S)-dSp and (R)-dSp62 m/z [M + H]+ calcd 300.2, found
300.1; HRMS (ESI-TOF) m/z [M + Na]+ calcd for C10H13N5O6Na
322.0764, found 322.0761; ESI+-MS/MS m/z [M + H]+ lit.22 184,
156, 141, 113, 99, and 86; found 184, 156, 141, 113, 99, and 86. dZ m/
z [M + H]+ calcd 247.2, found 247.1; HRMS (ESI-TOF) m/z [M +
Na]+ calcd for C8H14N4O5Na 269.0862, found 269.0870; ESI+-MS/
MS m/z [M + H]+ lit.67 247, 203, and 131; found 247, 203, and 131
(Figures S3−S13, Supporting Information). The dGh diastereomers
were characterized by NMR,44 dZ was characterized by NMR,30 cyclo-
dG was characterized by X-ray crystallography,68 the dSp diaster-
eomers have been characterized by X-ray crystallography69 and
NMR,70 and the diastereomers of d2Ih have been previously
characterized by NMR.37
Product Quantification. The oxidation products from the Fe(II)-
Fenton reaction or X-ray irradiation reaction were quantified by C18
reversed-phase HPLC and Hypercarb HPLC. First, the reaction
mixture was injected on a reversed-phase HPLC (250 mm × 4.6 mm,
5 μm) to quantify Gua, OG, dOG, and cyclo-dG. The void volume
from this run was collected, lyophilized to dryness, and then dissolved
with the Hypercarb column starting mobile phase (0.1% acetic acid).
Next, the reconstituted void volume was injected on a Hypercarb
column (150 mm × 4.6 mm, 5 μm) to quantify Gh, (R)-d2Ih, (S)-
d2Ih,42 dGh, (R)-dSp, (S)-dSp,62 and dZ. Product peaks were
quantified by their absorbance intensity at 240 nm followed by
normalization of these intensities by each compound’s extinction
coefficient at 240 nm. The values for ε240 nm (ddH2O) are dG 14 080,
dOG 14 300, cyclo-dG 14 080, Gua 14 080, OG 14 300,15 dSp 3280,22
d2Ih 2290,8,35 dGh and Gh 2410,54 and dZ 1780.67 All values are in
units of L mol−1 cm−1.
(3) Ames, B. N.; Sheigenaga, M. K.; Hagen, T. M. Biochem. Biophys.
Acta 1995, 1271, 165−170.
(4) Burrows, C. J.; Muller, J. G. Chem. Rev. 1998, 98, 1109−1152.
(5) Cadet, J.; Douki, T.; Gasparutto, D.; Ravanat, J.-L. Mutat. Res.
2003, 531, 5−23.
(6) Walling, C. Acc. Chem. Res. 1998, 31, 155−157.
(7) MacFaul, P. A.; Wayner, D. D. M.; Ingold, K. U. A. Acc. Chem.
Res. 1998, 31, 159−162.
(8) Fleming, A. M.; Muller, J. G.; Ji, I.; Burrows, C. J. Org. Biomol.
Chem. 2011, 9, 3338−3348.
(9) Cadet, J.; Douki, T.; Ravanat, J.-L. Acc. Chem. Res. 2008, 41,
1075−1083.
(10) Pratviel, G.; Meunier, B. Chem.Eur. J. 2006, 12, 6018−6030.
(11) Gimisis, T.; Cismas, C. Eur. J. Org. Chem. 2006, 1351−1378.
(12) Pogozelski, W. K.; Tullius, T. D. Chem. Rev. 1998, 98, 1089−
1108.
(13) Steenken, S.; Jovanovic, S. V.; Bietti, M.; Bernhard, K. J. Am.
Chem. Soc. 2000, 122, 2373−2374.
(14) Devasagayam, T. P.; Steenken, S.; Obendorf, M. S.; Schulz, W.;
Sies, H. Biochemistry 1991, 30, 6283−6289.
(15) Henle, E. S.; Luo, Y.; Gassmann, W.; Linn, S. J. Biol. Chem.
1996, 271, 21177−21186.
(16) Grey, C. E.; Adlercreutz, P. J. Agric. Food Chem. 2006, 54,
2350−2358.
(17) Belmadoui, N.; Boussicault, F.; Guerra, M.; Ravanat, J.-L.;
Chatgilialoglu, C.; Cadet, J. Org. Biomol. Chem. 2010, 8, 3211−3219.
(18) Pouget, J.-P.; Frelon, S.; Ravanat, J.-L.; Testard, I.; Odin, F.;
Cadet, J. Radiat. Res. 2002, 157, 589−595.
(19) Dizdaroglu, M.; Rao, G.; Halliwell, B.; Gajewski, E. Arch.
Biochem. Biophys. 1991, 285, 317−324.
(20) Douki, T.; Martini, R.; Ravanat, J.-L.; Turesky, R. J.; Cadet, J.
Carcinogenesis 1997, 18, 2385−2391.
(21) Gedik, C. M.; Collins, A. FASEB J. 2005, 19, 82−84.
(22) Luo, W.; Muller, J. G.; Rachlin, E. M.; Burrows, C. J. Org. Lett.
2000, 2, 613−616.
(23) Slade, P. G.; Hailer, M. K.; Martin, B. D.; Sugden, K. D. Chem.
Res. Toxicol. 2005, 18, 1140−1149.
(24) Misiaszek, R.; Crean, C.; Geacintov, N. E.; Shafirovich, V. J. Am.
Chem. Soc. 2005, 127, 2191−2200.
(25) Niles, J. C.; Wishnok, J. S.; Tannenbaum, S. R. Chem. Res.
Toxicol. 2004, 17, 1510−1519.
(26) Mangerich, A.; Knutson, C. G.; Parry, N. M.; Muthupalani, S.;
Ye, W.; Prestwich, E.; Cui, L.; McFaline, J. L.; Mobley, M.; Ge, Z.;
Taghizadeh, K.; Wishnok, J. S.; Wogan, G. N.; Fox, J. G.;
Tannenbaum, S. R.; Dedon, P. C. Proc. Natl. Acad. Sci. U.S.A. 2012,
109, E1820−E1829.
ASSOCIATED CONTENT
* Supporting Information
UPLC-ESI+-MS, HPLC-ESI+-MS, ESI+-MS/MS, reversed-
phase HPLC, Hypercarb HPLC, UV−vis spectra, and product
distribution tables. The Supporting Information is available free
■
S
(27) Hailer, M. K.; Slade, P. G.; Martin, B. D.; Sugden, K. D. Chem.
Res. Toxicol. 2005, 18, 1378−1383.
(28) Henderson, P. T.; Delaney, J. C.; Muller, J. G.; Neeley, W. L.;
Tannenbaum, S. R.; Burrows, C. J.; Essigmann, J. M. Biochemistry
2003, 42, 9257−9262.
(29) Delaney, J. C.; Neeley, W. L.; Delaney, J. C.; Essigmann, J. M.
Biochemistry 2007, 46, 1448−1455.
(30) Cadet, J.; Berger, M.; Buchko, G. W.; Joshi, P. C.; Raoul, S.;
Ravanat, J.-L. J. Am. Chem. Soc. 1994, 116, 7403−7404.
(31) Raoul, S.; Berger, M.; Buchko, G. W.; Joshi, P. C.; Morin, B.;
Weinfeld, M.; Cadet, J. J. Chem. Soc., Perkin Trans. 1996, 2, 371−381.
AUTHOR INFORMATION
Corresponding Author
Notes
■
The authors declare no competing financial interest.
K
J. Org. Chem. XXXX, XXX, XXX−XXX